What is the address of Dr. Habryialian?

The registered office of Dr. Habryialian is located at Barrierstraat 20, 3960 Bree.

Is Dr. Habryialian still active?

Yes. According to the CBE (31 October 2026) Dr. Habryialian is active, legal situation “Normale toestand”, started on 20 January 2020.

Is Dr. Habryialian registered on Peppol?

Yes, Dr. Habryialian is registered on the Peppol network with ID 0208:0741790771.

What is the enterprise number of Dr. Habryialian?

The enterprise number of Dr. Habryialian is BE0741790771.

When was Dr. Habryialian founded?

Dr. Habryialian was founded on 20 January 2020.

Who are the directors of Dr. Habryialian?

According to the 2025 annual accounts, the directors of Dr. Habryialian are: Alena Habryialian.

Is Dr. Habryialian a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 January 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Habryialian make in 2025?

Dr. Habryialian posted a profit after taxes of € 101,481 in financial year 2025.

What is the revenue of Dr. Habryialian?

As a small company, Dr. Habryialian is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 125,339.

Dr. Habryialian (Private Limited) - Bree - BE0741790771

Dossier Dr. Habryialian, printed on 31 October 2026 from databakkes.be/en/0741790771/dr-habryialian. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Habryialian from Bree, company number BE0741790771, closed financial year 2025 with a result of € 101,481 after tax. For that financial year Dr. Habryialian recorded a gross margin of € 125,339 and equity of € 168,718. Compared with financial year 2024, the result moved from € 119,299 to € 101,481. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.

What it is worth Healthy

€ 168,718

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 101,481

▼ 15% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 201,621

▲ 23% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 101,481 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 234

▼ 78% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,541

▲ 91% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 91,955 Gross margin 2022: € 91,955 First fiscal year in the series	€ 111,976 Gross margin 2023: € 111,976 ▲ 22% vs 2022 (€ 91,955) Favourable step	€ 152,383 Gross margin 2024: € 152,383 ▲ 36% vs 2023 (€ 111,976) Favourable step	€ 125,339 Gross margin 2025: € 125,339 ▼ 18% vs 2024 (€ 152,383) Unfavourable step	▼ 18%
Profit after taxes	€ 79,939 Profit after taxes 2022: € 79,939 First fiscal year in the series	€ 94,063 Profit after taxes 2023: € 94,063 ▲ 18% vs 2022 (€ 79,939) Favourable step	€ 119,299 Profit after taxes 2024: € 119,299 ▲ 27% vs 2023 (€ 94,063) Favourable step	€ 101,481 Profit after taxes 2025: € 101,481 ▼ 15% vs 2024 (€ 119,299) Unfavourable step	▼ 15%
Equity	€ 168,718 Equity 2022: € 168,718 First fiscal year in the series	€ 168,718 Equity 2023: € 168,718 Unchanged (€ 168,718) Unchanged	€ 168,718 Equity 2024: € 168,718 Unchanged (€ 168,718) Unchanged	€ 168,718 Equity 2025: € 168,718 Unchanged (€ 168,718) Unchanged
Total debts	€ 85,888 Total debts 2022: € 85,888 First fiscal year in the series	€ 95,634 Total debts 2023: € 95,634 ▲ 11% vs 2022 (€ 85,888) Unfavourable step	€ 131,949 Total debts 2024: € 131,949 ▲ 38% vs 2023 (€ 95,634) Unfavourable step	€ 104,022 Total debts 2025: € 104,022 ▼ 21% vs 2024 (€ 131,949) Favourable step	▼ 21%
Cash	€ 89,227 Cash 2022: € 89,227 First fiscal year in the series	€ 74,749 Cash 2023: € 74,749 ▼ 16% vs 2022 (€ 89,227) Unfavourable step	€ 163,612 Cash 2024: € 163,612 ▲ 119% vs 2023 (€ 74,749) Favourable step	€ 201,621 Cash 2025: € 201,621 ▲ 23% vs 2024 (€ 163,612) Favourable step	▲ 23%
Retained profit	€ 165,718 Retained profit 2022: € 165,718 First fiscal year in the series	€ 165,718 Retained profit 2023: € 165,718 Unchanged (€ 165,718) Unchanged	€ 165,718 Retained profit 2024: € 165,718 Unchanged (€ 165,718) Unchanged	€ 165,718 Retained profit 2025: € 165,718 Unchanged (€ 165,718) Unchanged
Dividend	€ 79,939 Dividend 2022: € 79,939 First fiscal year in the series	€ 94,063 Dividend 2023: € 94,063 ▲ 18% vs 2022 (€ 79,939) Unchanged	€ 119,299 Dividend 2024: € 119,299 ▲ 27% vs 2023 (€ 94,063) Unchanged	€ 101,481 Dividend 2025: € 101,481 ▼ 15% vs 2024 (€ 119,299) Unchanged	▼ 15%
Bank debt	€ 5,000 Bank debt 2022: € 5,000 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 5,000) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 254,606 Balance sheet total 2022: € 254,606 First fiscal year in the series	€ 264,352 Balance sheet total 2023: € 264,352 ▲ 4% vs 2022 (€ 254,606) Unchanged	€ 300,667 Balance sheet total 2024: € 300,667 ▲ 14% vs 2023 (€ 264,352) Unchanged	€ 272,740 Balance sheet total 2025: € 272,740 ▼ 9% vs 2024 (€ 300,667) Unchanged	▼ 9%

Key figures of Dr. Habryialian, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Habryialian?

What happened at Dr. Habryialian in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 15, 2026 New annual accounts for financial year 2025: profit of € 101,481 (▼ 15% vs 2024). Source: NBB ↗
Jan 20, 2020 New establishment in Bree. KBO
2020 Alena Habryialian became a director. NBB
Jan 20, 2020 Start of the company according to the CBE. KBO

In short

From € 79,939 profit in 2022 to € 101,481 profit in 2025.

Paid € 116,473 in corporate taxes since 2022.

Best year ever: 2024, with € 119,299 profit.

Paid out € 394,782 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Alena Habryialian

Dr. Habryialian

Behind Dr. Habryialian is Alena Habryialian.

Directors

According to the 2025 annual accounts

Alena Habryialian

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Barrierstraat 20

3960 Bree

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0741.790.771
VAT number: BE 0741.790.771
Registered office: Barrierstraat 20, 3960 Bree
Names & denominations: Dr. Habryialian
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 January 2020
Peppol: Active · Active since 26 Jan 2026

View on CBE Public ↗ Annual accounts (NBB) ↗